Found: 5
Select item for more details and to access through your institution.
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 322, doi. 10.1002/ajh.26447
- By:
- Publication type:
- Article
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 277, doi. 10.1002/ajh.24271
- By:
- Publication type:
- Article
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 774, doi. 10.1016/j.clml.2022.06.001
- By:
- Publication type:
- Article
Complete Response of Primary Refractory ALK-Positive Large B-Cell Lymphoma Treated With Single-Agent Nivolumab.
- Published in:
- 2020
- By:
- Publication type:
- case study
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 21, p. 3880, doi. 10.1002/cncr.34459
- By:
- Publication type:
- Article